CA2123611A1 - Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-myb - Google Patents
Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-mybInfo
- Publication number
- CA2123611A1 CA2123611A1 CA002123611A CA2123611A CA2123611A1 CA 2123611 A1 CA2123611 A1 CA 2123611A1 CA 002123611 A CA002123611 A CA 002123611A CA 2123611 A CA2123611 A CA 2123611A CA 2123611 A1 CA2123611 A1 CA 2123611A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- oligonucleotide
- mer
- oligodeoxynucleotide
- phosphorothioate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
- C12N2310/3125—Methylphosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79299991A | 1991-11-15 | 1991-11-15 | |
US792,999 | 1991-11-15 | ||
PCT/US1992/009656 WO1993009789A1 (fr) | 1991-11-15 | 1992-11-12 | Traitement d'un melanome au moyen d'oligonucleotides anti-codants par rapport au proto-oncogene c-myb |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2123611A1 true CA2123611A1 (fr) | 1993-05-27 |
Family
ID=25158769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002123611A Abandoned CA2123611A1 (fr) | 1991-11-15 | 1992-11-12 | Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-myb |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0667778A4 (fr) |
JP (1) | JPH07501525A (fr) |
AU (1) | AU3070992A (fr) |
CA (1) | CA2123611A1 (fr) |
WO (1) | WO1993009789A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5749847A (en) * | 1988-01-21 | 1998-05-12 | Massachusetts Institute Of Technology | Delivery of nucleotides into organisms by electroporation |
US5989849A (en) * | 1991-05-09 | 1999-11-23 | Temple University Of The Commonwealth System Of Higher Education | Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods |
US5646042A (en) * | 1992-08-26 | 1997-07-08 | Ribozyme Pharmaceuticals, Inc. | C-myb targeted ribozymes |
US5658780A (en) * | 1992-12-07 | 1997-08-19 | Ribozyme Pharmaceuticals, Inc. | Rel a targeted ribozymes |
WO1995011301A1 (fr) * | 1993-10-19 | 1995-04-27 | The Regents Of The University Of Michigan | Apoptose induite par p53 |
US5618709A (en) * | 1994-01-14 | 1997-04-08 | University Of Pennsylvania | Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US5994320A (en) * | 1995-02-06 | 1999-11-30 | Regents Of The University Of Minnesota | Antisense oligonucleotides and methods for treating central nervous system tumors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5098890A (en) * | 1988-11-07 | 1992-03-24 | Temple University-Of The Commonwealth System Of Higher Education | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
-
1992
- 1992-11-12 AU AU30709/92A patent/AU3070992A/en not_active Abandoned
- 1992-11-12 WO PCT/US1992/009656 patent/WO1993009789A1/fr not_active Application Discontinuation
- 1992-11-12 JP JP5509357A patent/JPH07501525A/ja active Pending
- 1992-11-12 CA CA002123611A patent/CA2123611A1/fr not_active Abandoned
- 1992-11-12 EP EP92924379A patent/EP0667778A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0667778A4 (fr) | 1997-04-16 |
WO1993009789A1 (fr) | 1993-05-27 |
EP0667778A1 (fr) | 1995-08-23 |
AU3070992A (en) | 1993-06-15 |
JPH07501525A (ja) | 1995-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5618709A (en) | Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein | |
US5734039A (en) | Antisense oligonucleotides targeting cooperating oncogenes | |
US5985558A (en) | Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos | |
AU641636B2 (en) | Antisense oligonucleotides to C-MYB proto-oncogene and uses thereof | |
JP2003524637A (ja) | Lna修飾オリゴヌクレオチドの治療上の使用 | |
ES2326118T3 (es) | Regulacion de la expresion del gen bcl-2. | |
KR20030034153A (ko) | Bcl-2 안티센스 올리고머를 이용한 bcl-2 질환의치료 방법 | |
WO1992022303A1 (fr) | INHIBITION SELECTIVE DE LA PROLIFERATION DES CELLULES LEUCEMIQUES PAR DES OLIGONUCLEOTIDES ANTI-CODANTS $i(BCR-ABL) | |
US5635385A (en) | Multi-unit ribozyme inhibition of oncogene gene expression | |
EP0668782B1 (fr) | Combinaison d'un agent anti-neoplasique et d'oligonucleotides antisens dans le traitement du cancer | |
US6015893A (en) | Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis | |
CA2123611A1 (fr) | Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-myb | |
Rubenstein et al. | Antisense oligonucleotide intralesional therapy for human PC‐3 prostate tumors carried in athymic nude mice | |
US5612212A (en) | Selective inhibition of cell proliferation by vav antisense oligonucleotides | |
WO1992020348A1 (fr) | Traitement de carcinome colo-rectal a l'aide d'oligonucleotides non codants par rapport au proto-oncogene c-myb | |
AU646643B2 (en) | Antisense oligonucleotides to C-ABL proto-oncogene | |
WO1994004137A1 (fr) | Oligonucleotides non codant complementaires du proto-oncogene de cycline d1 | |
WO1995024223A1 (fr) | Inhibition de la proliferation cellulaire par des oligonucleotides non codants specifiques contre e2f-1 | |
WO1998013072A1 (fr) | Compositions et procedes destines au traitement de la resistance multiple aux anticancereux | |
WO1994007538A1 (fr) | OLIGONUCLEOTIDES NON CODANTS DU PROTO-ONCOGENE B-m^_y^_b^ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |